Successful performance in proficiency testing (PT) is required

Size: px
Start display at page:

Download "Successful performance in proficiency testing (PT) is required"

Transcription

1 Performance Characteristics of Several Rules for Self-interpretation of Proficiency Testing Data R. Neill Carey, PhD; George S. Cembrowski, MD; Carl C. Garber, PhD; Zohreh Zaki, MD Context. Proficiency testing (PT) participants can interpret their results to detect errors even when their performance is acceptable according to the limits set by the PT provider. Objective. To determine which rules for interpreting PT data provide optimal performance for PT with 5 samples per event. Design. We used Monte Carlo computer simulation techniques to study the performance of several rules, relating their error detection capabilities to (1) the analytic quality of the method, (2) the probability of failing PT, and (3) the ratio of the peer group SD to the mean intralaboratory SD. Analytic quality is indicated by the ratio of the PT allowable error to the intralaboratory SD. Failure of PT was defined (Clinical Laboratory Improvement Amendments of 1988) as an event when 2 or more results out of 5 exceeded acceptable limits. We investigated rules with limits based on the SD index, the mean SD index, and percentages of allowable error. Results. No single rule performs optimally across the range of method quality. Conclusions. We recommend further investigation when PT data cause rejection by any of the following 3 rules: any result exceeds 75% of allowable error, the difference between any 2 results exceeds 4 times the peer group SD, or the mean SD index of all 5 results exceeds 1.5. As method quality increases from marginal to high, false rejections range from 16% to nearly zero, and the probability of detecting a shift equal to 2 times the intralaboratory SD ranges from 94% to 69%. (Arch Pathol Lab Med. 2005;129: ) Successful performance in proficiency testing (PT) is required of all clinical laboratories licensed under the provisions of the Clinical Laboratory Improvement Amendments of Acceptable limits are specified in terms of fixed concentrations, fixed percentages, a fixed concentration and a fixed percentage, or 3 times the PT peer group SD. Proficiency testing providers express participant results in a variety of formats. Some providers provide pass-fail scoring alone, while others provide SD index (SDI) scores and graphic presentations of each result s deviation from the target value as a percentage. When passing scores are obtained, users must interpret the PT data for themselves to determine whether the data indicate the presence of significant bias or random error. Careful self-examination of Clinical Laboratory Improvement Amendments of 1988 mandated PT data can be useful because there are 5 replicates in a single PT event, more than the 2 or 3 controls in a typical analytic run. Therefore, PT data have higher sensitivity to error than control data. The performance characteristics of several rules for interpreting PT data were previously studied. 2 Accepted for publication March 31, From the Peninsula Regional Medical Center, Salisbury, Md (Drs Carey and Zaki); University of Alberta Hospital, Capital Health Authority, Edmonton, Alberta (Dr Cembrowski); and Quest Diagnostics, Incorporated, Lyndhurst, NJ (Dr Garber). Dr Zaki is now with Doctors Pathology Services, Dover, Del. The authors have no relevant financial interest in the products or companies described in this article. Reprints: R. Neill Carey, PhD, Peninsula Regional Medical Center, 100 E Carroll St, Salisbury, MD ( neill.carey@ peninsula.org). Counting rules based on SDI limits and rules with limits based on the mean SDI were investigated. It was found that rule performance depended on the ratio of the survey group SD, s g, to the internal laboratory SD (intrainstrument SD), s i. It was also found that as s g /s i increases, the sensitivities of different rules change. While no single set of rules performed optimally throughout the range of s g / s i values encountered, screening with the SDI rule was recommended (see Table 1 for a list of rules investigated in the present study and their definitions). Follow-up was recommended on data that failed the screening rule with a combination of the and R 4.0 SDI or R 3.0 SDI rules to demonstrate random error and the x 1.5 SDI or x 1.0 SDI rules to demonstrate systematic error. The choice of range and mean rules depended on the value of s g /s i. In the present work, we studied the performance characteristics of additional rules and compared the sensitivities of the rules for detecting errors with the probability of failing PT. MATERIALS AND METHODS Using Minitab (Minitab Inc, State College, Pa), we designed a computer program similar to the one used previously to study the performance characteristics of different rules for interpreting PT results 2 and simulated PT performance for a typical automated chemistry analyzer. We used the group mean (x g) and group SD (s g ) for each PT sample from the 1991 College of American Pathologists C-C survey. 3 Three analytes were selected to span the range of quality (based on the ratio of allowable error to s i ) from Six Sigma 4 to marginal (Table 2): potassium, creatine kinase (CK), and iron. The intrainstrument SD (s i ) was obtained from the College of American Pathologists quality assurance group summary report for control products XLS-71 and XPS- Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al 997

2 Table 1. Quality Control Rules Studied*, at least 1 result exceeds x g 2.0 s g limit, at least 1 result in each of 2 events exceeds x g 2.0 s g limit, at least 2 results exceed x g 2.0 s g limit, at least 1 result exceeds x g 2.25 s g limit, at least 1 result exceeds x g 3.0 s g limit, at least 2 results exceed x g 3.0 s g limit x 1.0 SDI, mean of 5 samples exceeds x g 1.0 s g limit x 1.5 SDI, mean of 5 samples exceeds x g 1.5 s g limit R 3.0 SDI, difference between any 2 results exceeds 3.0 s g R 4.0 SDI, difference between any 2 results exceeds 4.0 s g, combination rule; invoke if any rule exceeds limit, 1 result exceeds 75% of analyte-specific allowable error 5 x &1 50% EA, all results are on the same side of the mean, and 1 result exceeds 50% of analyte-specific allowable error /5 x &1 50% EA, combination rule; invoke if any rule exceeds limit x 1.5 SDI / /R 4.0 SDI, combination rule; invoke if any rule exceeds limit 2 PT limit, fail PT event * SDI indicates SD index; x g, group mean; s g, group SD; EA, allowable error; and PT, proficiency testing. Table 2. Method Quality* Method Quality Sigma QC Requirement Unacceptable 2.0 Total analytic error cannot be maintained allowable error Marginal 2.0 to 3.0 QC procedures with high probability of false rejection and replicate measurements of patient and QC samples Fair 3.0 to 4.0 Multirule with 4 6 QC measurements per run Good 4.0 to 6.0 Multirule with 2 3 QC measurements per run Six Sigma 6.0 Weak QC procedures with 2 QC measurements per run * Adapted from Garber and Carey 4 and Westgard. 6 QC indicates quality control. Allowable error divided by intrainstrument SD, assuming bias is negligible. / combination control rule. For example, rule. 153, 5 which incorporated the data from approximately 30 Ortho Vitros 400s and 700s (formerly known as Kodak Ektachem). Control products XLS-71 and XPS-153 are aliquots of the same lot and were analyzed in the 1991 College of American Pathologists C-C survey. Parameter scenarios of simulated conditions for analytes are shown in Table 3. For potassium, s g /s i averaged We set the allowable error at 0.5 meq/l (Clinical Laboratory Improvement Amendments of 1988 limits 1 ). The ratio of allowable error to s i averaged 7.1, making the analytic quality of potassium at least Six Sigma (Table 2) using the classifications of Garber and Carey 4 and Westgard. 6 For CK, s g /s i averaged We set the allowable error at 15% (Quality Management Program Laboratory Services, previously Laboratory Proficiency Testing Program, Ontario Medical Association 7 ). The ratio of allowable error to s i averaged 3.8, making the quality of CK fair. For iron, s g /s i averaged We set the allowable error at 20% (Clinical Laboratory Improvement Amendments of 1988 limits). The ratio of allowable error to s i averaged 2.9, making the quality of iron marginal. For each analyte, we simulated trial analyses of groups of 5 PT samples per PT event. We quantified the performance characteristics of each rule in terms of its probability for false rejection (P fr, probability to signal an error for an event when only the inherent error of the method is present) and its probability for error detection (P ed, probability to signal an error for an event when increased systematic or random error is present). Figure 1 shows our concept of the performance characteristics of the ideal rule for interpreting PT data. The x-axis is the percentage of allowable error. At low percentages of allowable error, the probability of error detection (probability of rejection) for the rule is negligible. At a desired transition point, the probability of rejection increases rapidly until the rule is nearly 100% certain to reject and indicates that there is a potential problem with the method. Every rule has 3 performance characteristics: P fr, P ed for each amount of increased systematic error, and P ed for each amount of increased random error. We calculated P fr as the proportion of reject signals when only the inherent error of the method was included in the simulated events. We calculated P ed as the proportion of reject signals when each stated amount of systematic error (bias) or random error (imprecision) was included in the simulated events. We studied the rules listed in Table 1. These include the rules identified previously as optimally performing, 2 with exception of the SDI rule (which had high probability of false rejection, P fr.38 for potassium, a Six Sigma method). We included 2 new rules, (invoked when 1 result exceeds 75% of analytespecific allowable error, a near miss ) and 5 x &1 50% EA (invoked Table 3. Parameter Scenarios of Simulated Conditions for Analytes Analyte Units Allowable Error Group Mean Group SD Potassium meq/l 0.5 meq/l Creatine kinase U/L 15% Iron g/dl 20% Intrainstrument SD Sigma Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al

3 Figure 1. Power function for idealized proficiency testing rule. At low percentages of allowable error, the probability of rejection is negligible. At a desired transition point where the error is a significant proportion of allowable error, the probability of rejection increases dramatically. P ed indicates the probability for error detection. Figure 3. Performance characteristics of selected proficiency testing (PT) rules for systematic error for creatine kinase (mean s g /s i, 1.70; mean E A /s i, 3.8). P ed indicates the probability for error detection. Figure 2. Performance characteristics of selected proficiency testing (PT) rules for systematic error for potassium (mean s g /s i, 1.23; mean E A /s i, 7.1). P ed indicates the probability for error detection. Figure 4. Performance characteristics of selected proficiency testing (PT) rules for systematic error for iron (mean s g /s i, 2.68; mean E A /s i, 2.9). P ed indicates the probability for error detection. when all results are on the same side of the mean and 1 result exceeds 50% of allowable error). We also studied the probability of PT failure ( 2 results exceeding allowable error) as errors increase, to ascertain which rules can detect errors before PT failure occurs. We used the model for the participating laboratories used previously. 2 RESULTS Figures 2, 3, and 4 are graphs of the performance characteristics of selected rules for systematic error for potassium, CK, and iron, respectively. The x-axes of these figures differ slightly from the x-axis of Figure 1; they are labeled in terms of systematic error, expressed as bias measured in terms of the intrainstrument SD, s i.abiasof 0.0 s i corresponds to the probability of false rejection (P fr, the probability that the rule signals an error when none is present aside from the inherent random error of the method). Biases of 0.5 and 1.0 s i are small shifts relative to allowable error for most analytes, and biases of 2.0 and 3.0 s i are shifts that could cause PT problems for low-quality analytes. There are dramatic differences in the abilities of the different rules to detect errors that must be detected to pass PT. For potassium (Six Sigma quality), any rule except the rule will have sufficient power to detect significant errors without excessive false rejections. For iron (marginal quality at 2.9 Sigma), however, the only rules that can detect systematic error before there is significant risk of failing PT are the and 5 x &1 50% EA rules. Creatine kinase (fair quality at 3.8 Sigma) is transitional; the traditional counting rules detect significant errors; however, they are less sensitive than they are for potassium. The rule has a significant probability of false rejection for CK and iron (although less than the previously recommended SDI rule 2 ). In comparison, a quality control (QC) procedure for routine internal control with the 1 3s /2 2s combination control rule (a combination of the 1 3s and 2 2s control rules), using 2 controls, 8 has P ed of roughly.50 to detect a shift of 2.0 s i and a high probability of detecting a shift of 3.0 s i. Table 4 summarizes the performance of the rules we studied for detection of systematic error. Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al 999

4 x 1.0 SDI x 1.5 SDI Table 4. 5 x &1 50% EA /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI x 1.0 SDI x 1.5 SDI 5 x &1 50% EA /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI x 1.0 SDI x 1.5 SDI 5 x &1 50% EA /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI Probability of Error Detection for Candidate Rules to Detect Systematic Error* Intrainstrument SD Units * Abbreviations are explained in the footnote to Table 1. Potassium Creatine Kinase Iron Response to Random Error Figures 5, 6, and 7 are graphs of the performance characteristics of selected rules for random error for potassium, CK, and iron, respectively. The x-axes of these figures are labeled in terms of random error: 1.0 s i, corresponding to the probability of false rejection (P fr, only the inherent random error of the method is present); 2.0 s i, a doubling of random error; and 3.0 s i, a tripling of random error. As with systematic error, rules that perform well for potassium and even for CK have low sensitivity to significant errors with the marginal iron method. Therefore, for iron, only the rule can detect significant random errors with higher probability than the probability to fail PT. In comparison, QC rules for routine internal control also have low probability to detect random error. For a doubling of random error, the 1 3s /2 2s control procedure with 2 controls 8 has P ed of roughly.30 for detecting the increased error. For a tripling of random error, the same control procedure has P ed of roughly.60 for detecting the increased error. Table 5 summarizes the performance of the rules we studied for detection of random error. Suggested Combination Rule No single rule performs optimally across the range of method quality and s g /s i ; however, we were able to combine 3 rules sensitive to systematic and random errors for analytes with different method qualities to create a combination rule with broad sensitivity to systematic and random errors. The combination rule x 1.5 SDI / /R 4.0 SDI has sensitivity to systematic and random errors across the range of method quality we studied. Its P fr is high only for marginal methods. Power functions for this rule for systematic and random errors are shown in Figures 8 and 1000 Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al

5 Figure 5. Performance characteristics of selected proficiency testing (PT) rules for random error for potassium (mean s g /s i, 1.23; mean E A /s i, 7.1). P ed indicates the probability for error detection. Figure 6. Performance characteristics of selected proficiency testing (PT) rules for random error for creatine kinase (mean s g /s i, 1.70; mean E A /s i, 3.8). P ed indicates the probability for error detection. Table 5. R 3.0 SDI R 4.0 SDI Probability of Error Detection for Candidate Rules to Detect Random Error* /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI R 3.0 SDI R 4.0 SDI /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI Multiples of Intrainstrument SD Potassium Creatine Kinase Iron R 3.0 SDI R 4.0 SDI /5 x &1 50% EA x 1.5 SDI / /R 4.0 SDI * Abbreviations are explained in the footnote to Table 1. Figure 7. Performance characteristics of selected proficiency testing (PT) rules for random error for iron (mean s g /s i, 2.68; mean E A /s i, 2.9). P ed indicates the probability for error detection. 9. As method quality increases from marginal to Six Sigma, false rejections range from 16% to nearly zero, and the probability of detecting a shift equal to 2 times the intrainstrument SD ranges from 94% for the marginal method to 69% for the Six Sigma method. COMMENT Previously, screening PT data was recommended with the 2 1s rule and confirming error with the x 1.0 SDI,R 4.0 SDI,,1 1.5 SDI,andR 3.0 SDI rules, depending on the s g /s i of the method. 2,9 That work did not consider the relationship of allowable error and the s g /s i of the method and the ultimate risk of PT failure. The present work shows that this pathway had (1) high probability of false rejections and sensitivity to small, possibly insignificant errors for high-quality methods and (2) low sensitivity for significant errors for low-quality methods. We have become aware of more optimally performing rules that are based on the PT allowable error rather than the SDI. The rule we Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al 1001

6 Figure 8. Performance characteristics of x 1.5 SDI / /R 4.0 SDI combination rule for systematic error. P ed indicates the probability for error detection; CK, creatine kinase; and K, potassium. Figure 9. Performance characteristics of x 1.5 SDI / /R 4.0 SDI combination rule for random error. P ed indicates the probability for error detection; CK, creatine kinase; and K, potassium. are suggesting as the outcome of the present study, the x 1.5 SDI / /R 4.0 SDI combination rule, is much more reliable for detecting quality failures that threaten PT failure, if not corrected, and focuses remedial effort on lowerquality methods where PT failure is much more likely to occur. Proficiency testing results provide an opportunity for participants to detect errors that have been missed by their usual internal QC procedures, because internal QC limits are inappropriately large or the errors were missed during review of internal QC data, or because of matrix differences between the QC materials and the PT materials. Proficiency testing results potentially have higher probability to detect errors than internal QC results from a single run because there are 5 samples in a PT challenge versus the customary 2 or 3 samples used in internal QC. When a participant reviews the results of a PT event to check for rule failures, the SDI results and the pictorial display of the results must be examined. The pictorial display of results on College of American Pathologists survey reports makes it easy for the participant to detect and 5 x &1 50% EA rule failures. Examples of these failures are Figure 10. Example plots of the relative distance of results from targets as percentages of allowed deviation from a College of American Pathologists survey report demonstrating 1 75%EA (survey set C-C, 2003) and 5 x &1 50% EA (survey set C-B, 2003) rule failures. shown in Figure 10 as C-C and C-B, respectively. (Note added in proof: For 2005 surveys, CAP has changed the format and reduced the size of these plots.) We recommend inspecting PT data with the x 1.5 SDI / /R 4.0 SDI combination rule. It has high sensitivity to systematic and random errors that have significant probability of causing PT failure regardless of method quality. The x 1.5 SDI and R 4.0 SDI rules are sensitive to systematic and random errors, respectively, for high-quality methods and have near zero probability of false rejection. When PT data fail either of these rules, bias or random error is almost certain to be present. For mid- to low-quality methods, the rule is sensitive to systematic and random errors. When there is a failure of the rule, follow-up is necessary to determine whether the cause of the failure is systematic or random error or a false rejection. If the PT data also fail the 5 x &1 50% EA rule, systematic error is likely because sensitivity of this rule to systematic error is as good as that of the rule, after allowance for the P fr of the latter. For the analytes we studied, P fr for the 5 x &1 50% EA rule is.034 or less. The x 1.0 SDI rule, with P fr approaching zero, is also useful for confirming systematic error in intermediate-quality methods if there is failure of the rule without failure of the x 1.5 SDI rule. We do not recommend screening with the x 1.0 SDI rule because it is sensitive to small, probably insignificant systematic errors for Six Sigma methods. For all methods, comparison of internal QC data from the date of the PT event with peer group data may help confirm the presence of bias. Investigating rule failures for intermediate- and marginal-quality methods is difficult because of its high P fr (.16 for iron) and the lack of sensitivity of other rules for random error. If the PT data also fail the R 3.0 SDI rule, random error is confirmed; however, PT failure is more likely to occur than R 3.0 SDI rule failure (and even R 2.0 SDI rule failure 2 ) as random error increases for iron. The R 3.0 SDI rule is more sensitive to random error for CK (P ed for doubling of random error is.407 vs probability of PT failure of.059). Review of QC data from the time of the PT event for indications of random error may be helpful. Sometimes it is impossible to confirm whether a rule failure represents random error or false rejection. In this case, a check of within-run precision by running 5 to 10 replicates of control material or a patient specimen, calculating the within-run SD, and comparing it with the manufacturer s claim for within-run precision may be the simplest way to decide whether increased random error is present. Fig Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al

7 Figure 11. Flowchart for interpreting proficiency testing (PT) data with the recommended combination rule. QC indicates quality control. ure 11 is a flowchart for interpreting PT data with the recommended combination rule. Ultimately, a laboratory s PT performance for a particular method is limited by the inherent quality of the method. For example, if the best precision a laboratory can achieve with a given method is at the 3.0 Sigma level, this method is a potential source of PT problems. Laboratories must consider method quality during the selection process and, whenever possible, select methods with the best analytic performance. Information is available in manufacturers package inserts and published method evaluations. Then, the method must be evaluated to demonstrate that the user can achieve the quality the manufacturer has claimed. Clinical Laboratory Standards Institute (formerly NCCLS) guideline EP15-A provides a procedure for accomplishing this with minimal experimental effort. 10 Garber and Carey 4 and Westgard 11 provide guidance for performing method evaluations and interpreting method evaluation data. To maintain precision, laboratories should review method quality as new lots of control materials are introduced, by comparing the SD used to set control limits (representing the true performance of the QC procedure) with allowable error by calculating the Process Sigma (E A / s i ). Whenever the Process Sigma is less than 4, QC ranges must be carefully set to maintain sensitivity to error, and control failures must be investigated and problems corrected. If there is a high prevalence of errors, more sensitive control procedures should be implemented. These methods should be scrutinized in daily operation and should be improved or replaced. Whenever a laboratory selects a multitest automated testing system, there is a compromise of the quality of 1 or more methods to gain the other benefits of automation. Some analytes are generally problematic because state-ofthe-art precision performance is marginal with respect to allowable error; sodium and chloride are examples. There are problems when PT samples have low concentrations of some analytes, for example, urea nitrogen and whole blood ethanol. These 4 analytes have been sources of near misses in our laboratories. We thank Ray Gambino, MD, and Peter Mallon, PhD, for creating the concept of a near miss in reviewing PT in the late 1980s at Quest Diagnostics, Incorporated (MetPath, Inc, Teterboro, NJ). A near miss was defined as a result that was in the outer 25% of the acceptable range. This situation prompted an investigation into the cause for that result being so far off target and required implementation of appropriate corrective action, to prevent further degradation and failure on the next event. References 1. Medicare, Medicaid and CLIA programs: regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 57 Federal Register 7002 (1992). 2. Cembrowski GS, Hackney JR, Carey RN. The detection of problem analytes in a single proficiency test challenge in the absence of Health Care Financing Administration rule violations. Arch Pathol Lab Med. 1993;117: College of American Pathologists. Comprehensive Chemistry Survey: Set C- C. Northfield, Ill: College of American Pathologists; Garber CC, Carey RN. Evaluation of methods, In: Kaplan LA, Pesce AJ, eds. Clinical Chemistry: Theory, Analysis and Correlation. 4th ed. St Louis, Mo: CV Mosby Co; 2003: College of American Pathologists. Quality Assurance Services: Group Summary Report: Lot-Date Data Through June 1991, for Controls XLS-71 and XPS Northfield, Ill: College of American Pathologists; Westgard JO. Six Sigma Quality Design and Control. Madison, Wis: Westgard QC Inc; Ontario Medical Association. Cardiac Markers 0104: Survey Report. Toronto, Ontario: Laboratory Proficiency Testing Program, Ontario Medical Association; April Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem. 1981;27: Cembrowski GS. Thoughts on quality-control systems: a laboratorian s perspective. Clin Chem. 1997;43: Clinical Laboratory Standards Institute (formerly NCCLS). User Demonstration of Performance for Precision and Accuracy: Approved Guideline. Wayne, Pa: NCCLS; CLSI document EP15-A. 11. Westgard JO. Basic Method Validation. Madison, Wis: Westgard QC Inc; Arch Pathol Lab Med Vol 129, August 2005 Self-Interpretation of Proficiency Testing Data Carey et al 1003

Total Analytic Error From Concept to Application

Total Analytic Error From Concept to Application Página 1 de 5 Clinical Laboratory News Subscribe CLN Daily CLN Stat CLN Articles Total Analytic Error From Concept to Application Author: James O. Westgard, PhD, and Sten A. Westgard, MS // Date: SEP.1.2013

More information

Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk

Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk Designing QC Activities to More Precisely Manage Analytical Accuracy and Patient Risk Curtis A. Parvin, Ph.D. Manager of Advanced Statistical Research Bio-Rad Laboratories, QSD curtis_parvin@bio-rad.com

More information

Practical Guide to Running Controls

Practical Guide to Running Controls Practical Guide to Running Controls Internal quality control Introduction In addition to the competenceof the lab managerand the technical validation, the use and proper management of quality control (IQC,

More information

ARTICLES IMPACT STATEMENT ... September : JALM 211. Hassan Bayat, 1 Sten A. Westgard, 2 and James O.

ARTICLES IMPACT STATEMENT ... September : JALM 211. Hassan Bayat, 1 Sten A. Westgard, 2 and James O. Planning Risk-Based Statistical Quality Control Strategies: Graphical Tools to Support the New Clinical and Laboratory Standards Institute C24-Ed4 Guidance Hassan Bayat, 1 Sten A. Westgard, 2 and James

More information

Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation

Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation Establishing Quality Control Target Values and Standard Deviations for Hematology Instrumentation For informational purposes only. WHO REQUIRES IT AND WHAT THEY REQUIRE Regulatory agencies require the

More information

Quality Control in clinical laboratory. Kanit Reesukumal, M.D. Assistant Professor Clinical Pathology Mahidol University

Quality Control in clinical laboratory. Kanit Reesukumal, M.D. Assistant Professor Clinical Pathology Mahidol University Quality Control in clinical laboratory Kanit Reesukumal, M.D. Assistant Professor Clinical Pathology Mahidol University Outline Internal Quality Control Calculation Levey-Jennings Charts Westgard Rules

More information

Measurement Uncertainty Guide. ISO Accreditation Program

Measurement Uncertainty Guide. ISO Accreditation Program Measurement Uncertainty Guide ISO 15189 Accreditation Program Background Why This is Necessary The ISO 15189:2012 standard contains enhanced expectations regarding measurement uncertainty (MU) in clause

More information

Federal regulations (Clinical Laboratory Improvement

Federal regulations (Clinical Laboratory Improvement alibration Verification Performance Relates to Proficiency Testing Performance Martin H. roll, MD; Patricia E. Styer, PhD; Delmiro Anthony Vasquez, MT(ASP) ontext. Since 1988, the ollege of American Pathologists

More information

Allowable Imprecision for Laboratory Tests Based on Clinical and Analytical Test Outcome Criteria

Allowable Imprecision for Laboratory Tests Based on Clinical and Analytical Test Outcome Criteria CUN. CHEM. 40/10, 1909-1914 (1994) #{149} Laboratory Management and Utilization Allowable Imprecision for Laboratory Tests Based on Clinical and Analytical Test Outcome Criteria James 0. Westgard, Julie

More information

National External Quality Assurance Program Pakistan (NEQAPP) a milestone in proficiency testing in Pakistan

National External Quality Assurance Program Pakistan (NEQAPP) a milestone in proficiency testing in Pakistan National External Quality Assurance Program Pakistan (NEQAPP) a milestone in proficiency testing in Pakistan Muhammad Usman Munir 1, Aamir Ijaz 2 1 Department of Pathology, Combined Military Hospital,

More information

Common Deficiencies

Common Deficiencies Question text Deficiency #12: Does the laboratory have a documented system to ensure consistency of morphologic observations among all personnel performing (U/A, Micro, Hem) (sample) Suggested methods

More information

ACCESS Immunoassay System. HIV combo QC4 & QC5. For monitoring the system performance of the Access HIV combo assay. B71107A - [EN] /01

ACCESS Immunoassay System. HIV combo QC4 & QC5. For monitoring the system performance of the Access HIV combo assay. B71107A - [EN] /01 ACCESS Immunoassay System HIV combo QC4 & QC5 B22822 For monitoring the system performance of the Access HIV combo assay. - [EN] - 2015/01 Table of Contents Access HIV combo QC4 & QC5 1 Intended Use...

More information

Quality Management of the Total Examination Process. Elvar Theodorsson

Quality Management of the Total Examination Process. Elvar Theodorsson Quality Management of the Total Examination Process Elvar Theodorsson 2 The total testing chain consists of much more than the analytical phase The true value of laboratory results are expressed in their

More information

Variability of Laboratory Test Results

Variability of Laboratory Test Results Clinical Chemistry / VARIABILITY OF LABORATORY TEST RESULTS Variability of Laboratory Test Results Shahram Shahangian, PhD, 1 and Richard D. Cohn, PhD 2 Key Words: Variability of laboratory results; Laboratory

More information

Proficiency Testing Schemes and Traceability: the College of American Pathologists (CAP) Perspective John H. Eckfeldt, MD, PhD

Proficiency Testing Schemes and Traceability: the College of American Pathologists (CAP) Perspective John H. Eckfeldt, MD, PhD Proficiency Testing Schemes and Traceability: the College of American Pathologists (CAP) Perspective John H. Eckfeldt, MD, PhD Medical Director, Clinical Pathology, Fairview-University Medical Center Professor,

More information

QUALITY CONTROL & STANDARD OPERATING PROCEDURES EHI JAMES OCHEIKWU.

QUALITY CONTROL & STANDARD OPERATING PROCEDURES EHI JAMES OCHEIKWU. QUALITY CONTROL & STANDARD OPERATING PROCEDURES EHI JAMES OCHEIKWU. OUTLINE Introduction Quality Control - Meaning Types of Quality Control Monitoring of Quality Control Multi-rule Quality Control Quality

More information

Plan Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail PRINCIPLE:

Plan Subject Index Number Section Subsection Category Contact Last Revised References Applicable To Detail PRINCIPLE: Subject Quality Assurance for Laboratory Testing Index Number Lab-0135 Section Laboratory Subsection Laboratory - General Category Departmental Contact Nancy Ekern Last Revised 7/27/2017 References Required

More information

S1725 Method Validation and Verification: Case Studies and Laboratory Challenges

S1725 Method Validation and Verification: Case Studies and Laboratory Challenges S1725 Method Validation and Verification: Case Studies and Laboratory Challenges James H. Nichols, PhD, D(ABCC) Lauren N. Person, DO, MPH, FCAP Objectives Identify the difference between method validation

More information

Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey

Internal Quality Control Practices in Coagulation Laboratories: recommendations based on a patterns-of-practice survey International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Internal Quality

More information

Verifying New Reagent Lot Performance

Verifying New Reagent Lot Performance Verifying New Reagent Lot Performance Julianne Addison Application Consultant, Siemens RSC Answers for life. Objectives Describe issues relating to changing reagent lots Discuss the reasons QC material

More information

Verification of Method XXXXXX

Verification of Method XXXXXX Reviewed By: Date: Technical Supervisor Reviewed By: Date: General Supervisor Reviewed By: Date: Quality Assurance Coordinator Approved By: Date: Director Page 1 of 11 Table of Contents Purpose and Principle:...

More information

Quality Control for Chemistry Laboratory Dynacare Kasper Laboratories Procedures

Quality Control for Chemistry Laboratory Dynacare Kasper Laboratories Procedures 54 Quality Control for Chemistry Laboratory Dynacare Kasper Laboratories Procedures Lorena Ivona Stefan 1*, Deborah Reid 2 1. Emergency Clinical Hospital, Laboratory Medical Analysis, Craiova, Romania

More information

Guide to Fulfillment of Validation and Verification of Examination Requirements

Guide to Fulfillment of Validation and Verification of Examination Requirements DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca

More information

Implementation Guide. 3a. Skills Checklist. 3b. Competency Exam. 3c. Answer Key: Competency Exam. 3d. Competency Assessment Checklist

Implementation Guide. 3a. Skills Checklist. 3b. Competency Exam. 3c. Answer Key: Competency Exam. 3d. Competency Assessment Checklist Implementation Guide TABLE OF CONTENTS SECTION 1 Introduction SECTION 2 Pre-Implementation Checklist SECTION 3 Introduction: Operator Training and Competency Certification 3a. Skills Checklist 3b. Competency

More information

Advances in Biochemistry & Applications in Medicine

Advances in Biochemistry & Applications in Medicine Advances in Biochemistry & Applications in Medicine Chapter 1 ISBN: 978-93-87500-49-5 Quality Control in a Clinical Laboratory Vaneet Kaur 1 ; Pawan Kumar Kare 1* ; Himanshu Madaan 1 1 Department of Biochemistry,

More information

Guide to Fulfillment of Laboratory Results Comparability Requirements

Guide to Fulfillment of Laboratory Results Comparability Requirements DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca

More information

Validation of a quality assessment system for blood gas and electrolyte testing

Validation of a quality assessment system for blood gas and electrolyte testing Clinica Chimica Acta 382 (2007) 65 70 www.elsevier.com/locate/clinchim Validation of a quality assessment system for blood gas and electrolyte testing John G. Toffaletti a,, Elizabeth H. McDonnell a, Lakshmi

More information

MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D.

MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS. Richard L. Hodinka, Ph.D. MOLECULAR TESTING: VERIFYING/VALIDATING INSTRUMENTS, REAGENTS AND ASSAYS Richard L. Hodinka, Ph.D. University of South Carolina School of Medicine Greenville Greenville Health System, Greenville, SC hodinka@greenvillemed.sc.edu

More information

Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise!

Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise! Validating, Verifying, and Evaluating Your Test Methods: It s NOT a Regulatory Exercise! Pat Garrett, Ph.D., DABCC Renee Howell, Ph.D., MT(ASCP) SeraCare Life Sciences, Inc. AACC Annual Meeting July 29,

More information

Urinalysis and Body Fluids CRg. Laboratory Regulation. Laboratory Regulation for Quality Assessment. Unit 1 B. Quality Assessment

Urinalysis and Body Fluids CRg. Laboratory Regulation. Laboratory Regulation for Quality Assessment. Unit 1 B. Quality Assessment Urinalysis and Body Fluids CRg Unit 1 B Laboratory Regulation Federal Regulations / Regulatory Organizations Laboratory structure / operation Quality test performed by qualified personnel to obtain quality

More information

A Practical Guide to Internal Quality Control (IQC) For Quantitative Tests in Medical Laboratories, Version 2.0 February 2015

A Practical Guide to Internal Quality Control (IQC) For Quantitative Tests in Medical Laboratories, Version 2.0 February 2015 Dear Colleagues, A Practical Guide to Internal Quality Control (IQC) For Quantitative Tests in Medical Laboratories, Version 2.0 February 2015 Time flies! This is a substantial revision of the previous

More information

Interpretation of External Quality Assurance: How to and How Not to

Interpretation of External Quality Assurance: How to and How Not to Original Article Interpretation of External Quality 10.5005/jp-journals-10054-0044 Assurance: How to and How Not to Interpretation of External Quality Assurance: How to and How Not to 1 Satish Ramanathan,

More information

Master. Chemistry and Toxicology Checklist. CAP Accreditation Program

Master. Chemistry and Toxicology Checklist. CAP Accreditation Program Master Chemistry and Toxicology Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.17.2016 2 of 76 Disclaimer and Copyright

More information

What is? An Overview of Operational Processes

What is? An Overview of Operational Processes Friday April 7, 2017 LD4 What is? An Overview of Operational Processes John T. Daly, MD, FCAP Chief Medical Officer, COLA DESCRIPTION: This session focuses on other important topics for the laboratory

More information

Strengthening Laboratory Management Toward Accreditation. Module 6: Quality Assurance

Strengthening Laboratory Management Toward Accreditation. Module 6: Quality Assurance Strengthening Laboratory Management Toward Accreditation Module 6: Quality Assurance Key Message My lab assures accurate and reliable testing processes. Desired Outcome Consistently accurate and reliable

More information

The International Haemostasis External Quality Control Program

The International Haemostasis External Quality Control Program The International Haemostasis External Quality Control Program Intended use of Quality Control Primary Purpose of the Clinical Laboratory To produce accurate results that will correctly diagnose and interpret

More information

Today s Featured Speaker

Today s Featured Speaker Today s Featured Speaker Judy Yost, M.A., M.T.(ASCP) received her B.S. Degree at Wilkes College and her M.A. in hospital management from Central Michigan University. She is an American Society for Clinical

More information

SAMPLE. Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures

SAMPLE. Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures 2nd Edition EP21 Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures This guideline provides manufacturers and end users with an understanding of concepts related

More information

Today s Featured Speaker

Today s Featured Speaker Today s Featured Speaker Judy Yost, M.A., M.T.(ASCP) received her B.S. Degree at Wilkes College and her M.A. in hospital management from Central Michigan University. She is an American Society for Clinical

More information

2008 HFC-A PARTICIPANT SUMMARY

2008 HFC-A PARTICIPANT SUMMARY 2008 HFC-A PARTICIPANT SUMMARY Evaluation Criteria Analyte Target Value Evaluation Criteria Red Blood Cell Peer Group ± 3 SD White Blood Cell Peer Group ± 3 SD Cytopreparation Differential Educational

More information

ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories

ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories Veterinary Clinical Pathology ISSN 0275-6382 SPECIAL REPORT ASVCP quality assurance guidelines: control of general analytical factors in veterinary laboratories Bente Flatland 1, Kathy P. Freeman 2, Kristen

More information

USE OF INFORMATICS IN ANALYTICAL QUALITY

USE OF INFORMATICS IN ANALYTICAL QUALITY USE OF INFORMATICS IN ANALYTICAL QUALITY DR SUVIN SHETTY MD HEAD, DEPT OF LABORATORY MEDICINE DR L H HIRANANDANI HOSPITAL, MUMBAI 4/14/2017 Dr Suvin Shetty, Informatics In Analytical Quality 1 DR L H HIRANANDANI

More information

Verification or validation, that is the question

Verification or validation, that is the question Perspective Page 1 of 7 Verification or validation, that is the question Giorgia Antonelli 1, Andrea Padoan 1, Ada Aita 1, Laura Sciacovelli 2, Mario Plebani 1,2 1 U.O.C. of Laboratory Medicine, Department

More information

CLSI C60: Assay Validation & Post-Validation Monitoring

CLSI C60: Assay Validation & Post-Validation Monitoring CLSI C60: Assay Validation & Post-Validation Monitoring Ross J. Molinaro, MT(ASCP), PhD, DABCC, FACB Medical Director Core Laboratory, Emory University Hospital Midtown Emory Clinical Translational Research

More information

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology Francis E. Sharkey, MD, FCAP University of Texas Health Science Center, San Antonio, TX Richard W. Brown, MD, FCAP Memorial

More information

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy

Guidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy Guidance for Industry and FDA Staff Replacement Reagent and Instrument Family Policy Document issued on: December 11, 2003 This document supersedes Data for Commercialization of Original Equipment Manufacturers

More information

Establishing Chemistry QC Ranges

Establishing Chemistry QC Ranges Chemistry Guideline for Establishing New Control Lot Means and Quality Control (QC) Ranges Through Parallel Testing and Historic Coefficient of Variation (%CV h ) Authored by Kurt Michael and Paul Richardson

More information

The road to a perfect EQA-programme

The road to a perfect EQA-programme The road to a perfect EQA-programme The Dutch SKML experience Christa Cobbaert DEPARTMENT OF CLINICAL CHEMISTRY AND LABORATORY MEDICINE, LEIDEN UNIVERSITY MEDICAL CENTRE, LEIDEN, THE NETHERLANDS Content

More information

Which skills are needed and how they should be gained by laboratory medicine professionals for successful ISO accreditation

Which skills are needed and how they should be gained by laboratory medicine professionals for successful ISO accreditation Meeting the needs of Mediterranean nations: improving efficiency in laboratory medicine This is a Platinum Open Access Journal distributed under the terms of the Creative Commons Attribution Non-Commercial

More information

LabGuide 13 How to Verify Performance Specifications

LabGuide 13 How to Verify Performance Specifications 1 LG 13 Comments? Feedback? Questions? Email us at info@cola.org or call us at 800 981-9883 LabGuide 13 How to Verify Performance Specifications The verification of performance specifications confirms

More information

CLIA Personnel & Competency Requirements

CLIA Personnel & Competency Requirements Friday April 7, 2017 D32 CLIA Personnel & Competency Requirements John T. Daly, MD, FCAP Chief Medical Officer, COLA DESCRIPTION: In addition to the laboratory director, the CLIA regulations specify personnel

More information

Ready, Set, Test! AACC Conference Mass Spectrometry in the Clinical Lab: Best Practice and Current Applications September 17-18, 2013 St.

Ready, Set, Test! AACC Conference Mass Spectrometry in the Clinical Lab: Best Practice and Current Applications September 17-18, 2013 St. Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference

More information

WAIT! Ready, Set, Test! Financial Disclosure. Research/Educational grants/consulting/salary support

WAIT! Ready, Set, Test! Financial Disclosure. Research/Educational grants/consulting/salary support Ready, Set, Test! Ross Molinaro, PhD, MLS(ASCP) CM, DABCC, FACB Medical Director, Clinical Laboratories Emory University Hospital Midtown Emory Clinical Translational Research Laboratory AACC Conference

More information

Assay Validation Services

Assay Validation Services Overview PierianDx s assay validation services bring clinical genomic tests to market more rapidly through experimental design, sample requirements, analytical pipeline optimization, and criteria tuning.

More information

SMILE Johns Hopkins University Baltimore, MD USA. Guidelines for Manual Evaluation of CAP Hemocytometer Fluid Count

SMILE Johns Hopkins University Baltimore, MD USA. Guidelines for Manual Evaluation of CAP Hemocytometer Fluid Count SMILE Johns Hopkins University Baltimore, MD USA Guidelines for Manual Evaluation of CAP Hemocytometer Fluid Count Author: Heidi Hanes, BS, MT (ASCP) SH Document Number: Pro22-25 Effective (or Post) Date:

More information

SAMPLE. Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking

SAMPLE. Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking 1st Edition EP34 Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking It is often medically necessary to provide results for specimens with concentrations above

More information

Quality Control Program

Quality Control Program Quality Control Program Online Interlaboratory Comparison Program C Quality Control Program C Quality Control Program Get the most Powerful Program to Pilot your Analytical Performance Intelligent and

More information

ISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparison

ISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparison ISO 13528:2015 Statistical methods for use in proficiency testing by interlaboratory comparison ema training workshop August 8-9, 2016 Mexico City Class Schedule Monday, 8 August Types of PT of interest

More information

LabDAQ Laboratory Information System (LIS) is a scalable solution trusted by thousands of physicians and laboratory professionals every day.

LabDAQ Laboratory Information System (LIS) is a scalable solution trusted by thousands of physicians and laboratory professionals every day. Sample Reports LabDAQ Laboratory Information System (LIS) is a scalable solution trusted by thousands of physicians and laboratory professionals every day. Experience the power of LabDAQ. Table of Contents

More information

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program CHEMISTRY AND TOXICOLOGY CHECKLIST

COMMISSION ON LABORATORY ACCREDITATION. Laboratory Accreditation Program CHEMISTRY AND TOXICOLOGY CHECKLIST Revised: 04/06/2006 COMMISSION ON LABORATORY ACCREDITATION Laboratory Accreditation Program CHEMISTRY AND TOXICOLOGY CHECKLIST Disclaimer and Copyright Notice The College of American Pathologists (CAP)

More information

Discover the Importance of Third Party Quality Control

Discover the Importance of Third Party Quality Control Bio-Rad Laboratories Q U A L I T Y C O N T R O L Discover the Importance of Third Party Quality Control Introduce Your Laboratory to an Independent Assessment Bio-Rad Laboratories Q U A L I T Y C O N T

More information

IQCP for Commercial Antimicrobial Susceptibility Testing (AST) System XYZ

IQCP for Commercial Antimicrobial Susceptibility Testing (AST) System XYZ Please note that some references to protocol, publications, performance data etc. are fictitious in this EXAMPLE. Please use your own DATA for your IQCP. The following represents one example of how you

More information

Case Study College of American Pathologists. All rights reserved. cap.org

Case Study College of American Pathologists. All rights reserved. cap.org Case Study How to Reduce Clerical Errors Mark Shearer, MCLT, MT(ASCP) Director of Chemistry, CompuNet Clinical Laboratories Clerical errors represent the single largest source of errors on proficiency

More information

Importance of Third Party Quality Controls

Importance of Third Party Quality Controls QUALITY CONTROL Importance of Third Party Quality Controls Complete QC solutions for results you can trust Quality Control qual-ity con-trol Noun A system of maintaining standards in manufactured products

More information

Statements on the Regulation of Laboratory Developed Tests

Statements on the Regulation of Laboratory Developed Tests Statements on the Regulation of Laboratory Developed Tests Current Regulatory Gaps and Perspectives on Oversight of LDTs American Cancer Society Cancer Action Network says Molecular tests, in particular,

More information

External Quality Assurance Scheme (EQAS): Criteria for Evaluating Performance of a Laboratory

External Quality Assurance Scheme (EQAS): Criteria for Evaluating Performance of a Laboratory IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) ISSN: 2455-264X, Volume 4, Issue 4 (Jul. Aug. 2018), PP 16-20 www.iosrjournals.org External Quality Assurance Scheme (EQAS): Criteria for Evaluating

More information

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center

Laboratory Developed Tests. William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Laboratory Developed Tests William Castellani, MD Inter-regional Commissioner Clinical Pathologist, Penn State Hershey Medical Center Objectives Compare and contrast new test validation requirements for

More information

Improvement of the Quality of Work in a Biochemistry Laboratory via Measurement System Analysis

Improvement of the Quality of Work in a Biochemistry Laboratory via Measurement System Analysis Chinese Journal of Physiology 59(5): 93-99, 016 93 DOI: 10.4077/CJP.016.BAF45 Improvement of the Quality of Work in a Biochemistry Laboratory via Measurement System Analysis Ming-Shu Chen 1, Chen-Mao Liao,

More information

Defining Analytical Performance Specifications

Defining Analytical Performance Specifications Defining Analytical Performance Specifications Matthias Orth IFCC Committee on Clinical Laboratory Management - http://www.ifcc.org/ifcc-education-division/emd-committees/c-clm/ Satellite Educational Workshop

More information

WEQAS: what is it and what does it mean?. Celia Critchley Point of Care Co-ordinator Warrington and Halton Hospitals NHS Foundation Trust

WEQAS: what is it and what does it mean?. Celia Critchley Point of Care Co-ordinator Warrington and Halton Hospitals NHS Foundation Trust WEQAS: what is it and what does it mean?. Celia Critchley Point of Care Co-ordinator Warrington and Halton Hospitals NHS Foundation Trust Objectives Overview of External Quality Assessment and its relevance

More information

Competency Assessment: Is Your Program Competent? Judy Sullivan, MS, MT(ASCP)SBB HAABB Meeting April 30, 2013

Competency Assessment: Is Your Program Competent? Judy Sullivan, MS, MT(ASCP)SBB HAABB Meeting April 30, 2013 Competency Assessment: Is Your Program Competent? Judy Sullivan, MS, MT(ASCP)SBB HAABB Meeting April 30, 2013 Objectives Discuss requirements related to competency assessment Describe what assessors, inspectors,

More information

Guidelines for Use of Back-Up Equipment and Back-up Clinical Laboratories for Safety Testing in DAIDS-Sponsored Clinical Trials

Guidelines for Use of Back-Up Equipment and Back-up Clinical Laboratories for Safety Testing in DAIDS-Sponsored Clinical Trials Notes An earlier version of this document was drafted by Paul Richardson, Estelle Piwowar-Manning, Erin Gover, and Kurt Michael. The document was finalized by the Cross-Network Laboratory Focus Group (LFG),

More information

Clinical Chemistry Approach to Evaluation of Commutability

Clinical Chemistry Approach to Evaluation of Commutability Clinical Chemistry Approach to Evaluation of Commutability Hubert W. Vesper, Ph.D. Director, Clinical Standardization Programs Division of Laboratory Sciences Centers for Disease Control and Prevention,

More information

For In Vitro Diagnostic Use

For In Vitro Diagnostic Use SYNCHRON System(s) Chemistry Information Sheet Lactate Dehydrogenase REF 442660 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE INTENDED USE reagent, when used in

More information

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys.

Date. Albumin measurements are used in the diagnosis and treatment of numerous diseases primarily involving the liver and/or kidneys. SYNCHRON System(s) Chemistry Information Sheet Copyright 2013 Beckman Coulter, Inc. Albumin REF 442765 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by Date Reviewed by Date PRINCIPLE INTENDED USE

More information

2009 LAP Audioconference Series. Simple Tests, Tough Problems Patient Care and Laboratory Inspection in Coagulation

2009 LAP Audioconference Series. Simple Tests, Tough Problems Patient Care and Laboratory Inspection in Coagulation 2009 LAP Audioconference Series Simple Tests, Tough Problems Patient Care and Laboratory Objectives: After participating in this session, you will be able to: to describe patient care and accreditation

More information

March 19, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852

March 19, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 March 19, 2018 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 RE: Docket No. FDA-2017-D-6765; Draft Guidance for Industry and Food

More information

Laboratory Quality Control Management System. A New Approach to Quality Control

Laboratory Quality Control Management System. A New Approach to Quality Control Laboratory Quality Control Management System A New Approach to Quality Control Overview Provide hospitals and reference laboratories with tools to capture Quality Control (QC)/Proficiency Testing (PT)

More information

September 8, General Comments:

September 8, General Comments: September 8, 2009 AMP Comments on the draft report from the Agency for Healthcare Research and Quality (AHRQ): AHRQ Draft Report on Quality, Regulation and Clinical Utility of Laboratorydeveloped Tests.

More information

Confirm assay performance Identify poor assay performance. Confirm correction of poor performance

Confirm assay performance Identify poor assay performance. Confirm correction of poor performance Performance criteria for EQA schemes need for harmonization Graham Jones Department of Chemical Pathology St Vincent s Hospital, Sydney Milan November 2014 The Role of External Quality Assurance Confirm

More information

- - - Backup_Lab_Guidelines v

- - - Backup_Lab_Guidelines v - - - Backup_Lab_Guidelines v2.0 2010-11-10 Table of Contents Introduction... 1 Back-Up Guidelines for Safety Testing Laboratories... 2 Introduction... 2 Development and review of the back-up plan... 2

More information

SEED HAEMATOLOGY. SNCS IQAS Online the quality control solution for the haematology laboratory

SEED HAEMATOLOGY. SNCS IQAS Online the quality control solution for the haematology laboratory SYSMEX EDUCATIONAL ENHANCEMENT AND DEVELOPMENT NOVEMBER 2015 SEED HAEMATOLOGY SNCS IQAS Online the quality control solution for the haematology laboratory Introduction It is standard practice for laboratories

More information

The Validity of Proficiency Testing: A Review of Data from the College of American Pathologists Laboratory Improvement Programs

The Validity of Proficiency Testing: A Review of Data from the College of American Pathologists Laboratory Improvement Programs 1995 Institute: Frontiers in Laboratory Practice Research 95 The Validity of Proficiency Testing: A Review of Data from the College of American Pathologists Laboratory Improvement Programs Noel S. Lawson,

More information

Quality Control: Tips, Troubleshooting, and Tidbits

Quality Control: Tips, Troubleshooting, and Tidbits Quality Control: Tips, Troubleshooting, and Tidbits Nancy May, MBA, MT(ASCP) Technical Integration Specialist Agenda: 4 Tips 2 Troubleshootings Tools: Detector Parameters XbarM Tidbits 2 Sysmex America

More information

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS

CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS CONCURRENT 10: THE COMPLETE BLOOD COUNT AND BEYOND: QUALITY ISSUES AND REFERENCE METHODS Saturday May 14 th 2016 1:30 3:00 PM (13.30 15.00hrs) International Society for Laboratory Hematology (ISLH) CONCURRENT

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1 A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

Reference systems and international standardisation of measurements for clinically important enzymes

Reference systems and international standardisation of measurements for clinically important enzymes Reference systems and international standardisation of measurements for clinically important enzymes VII th Czech National Congress of Clinical Biochemistry (11. 13.9.2005, Olomouc) Gerhard Schumann, Klinische

More information

Quality Assurance by Liz McChlery

Quality Assurance by Liz McChlery Quality Assurance by Liz McChlery Define QA and Total Quality Management Describe Quality Control Define and distinguish Accuracy and Precision Define a Biological Reference Interval Describe ISO15189

More information

Master. Immunology Checklist. CAP Accreditation Program

Master. Immunology Checklist. CAP Accreditation Program Master Immunology Checklist CAP Accreditation Program College of American Pathologists 325 Waukegan Road Northfield, IL 60093-2750 www.cap.org 08.17.2016 2 of 33 Disclaimer and Copyright Notice On-site

More information

Monitoring and improvement of intralaboratory turnaround time at the university hospital Campus Bio-Medico in Rome

Monitoring and improvement of intralaboratory turnaround time at the university hospital Campus Bio-Medico in Rome SCIENTIFIC PAPERS CONTRIBUTI SCIENTIFICI Monitoring and improvement of intralaboratory turnaround time at the university hospital Campus Bio-Medico in Rome Silvia Angeletti 1, Marina De Cesaris 1, Siriana

More information

IQCP for the Akers Bio PIFA PlussPF4 Rapid Assay

IQCP for the Akers Bio PIFA PlussPF4 Rapid Assay On December 31, 2015 the ability to use Equivalent Quality Control (EQC) policies will expire. Laboratories will be required to either follow the quality control regulations as outlined in CLIA 88 or develop

More information

Sysmex Educational Enhancement and Development No

Sysmex Educational Enhancement and Development No SEED Haematology Sysmex Educational Enhancement and Development No 2 2015 SNCS the quality control solution for the haematology laboratory The purpose of this newsletter is to provide an overview of the

More information

SAMPLE. Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline Second Edition

SAMPLE. Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline Second Edition November 2009 Risk Management Techniques to Identify and Control Laboratory Error Sources; Approved Guideline Second Edition This guideline describes risk management techniques that will aid in identifying,

More information

Developing an Individualized Quality Control Plan (IQCP) For Cepheid s GeneXpert Diagnostic Systems

Developing an Individualized Quality Control Plan (IQCP) For Cepheid s GeneXpert Diagnostic Systems Developing an Individualized Quality Control Plan (IQCP) For BACKGROUND On January 1, 2014, the Center for Medicare and Medicaid Services (CMS) adopted an alternative Quality Control (QC) procedure that

More information

Design and implementation of a microchemistry analyzer

Design and implementation of a microchemistry analyzer Pure & App/. Chem., Vol. 68, No. 10, pp. 1837-1841, 1996. Printed in Great Britain. Q 1996 IUPAC Design and implementation of a microchemistry analyzer Nina Peled, PhD i-stat Corporation 303 College Road

More information

Diagnostic Accreditation Program 2015 Laboratory Medicine Accreditation Standards FAQ

Diagnostic Accreditation Program 2015 Laboratory Medicine Accreditation Standards FAQ Diagnostic Accreditation Program 2015 Laboratory Medicine Accreditation Standards FAQ If you have questions about items in the standards please email them to: laboratorymedicine@cpsbc.ca Click on an item

More information

Mathematical Analysis of Cervical Cancer Screening Policies (Does the Federal Requirement Make Any Sense?)

Mathematical Analysis of Cervical Cancer Screening Policies (Does the Federal Requirement Make Any Sense?) Mathematical Analysis of Cervical Cancer Screening Policies (Does the Federal Requirement Make Any Sense?) James C. Benneyan, Ph.D. Northeastern University, Boston MA benneyan@coe.neu.edu ABSTRACT This

More information

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

PAB PRINCIPLE. Kit Reorder # ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE SYNCHRON CX System(s) Chemistry Information Sheet Copyright 2008 Beckman Coulter, Inc. Prealbumin Kit Reorder # 475106 For In Vitro Diagnostic Use ANNUAL REVIEW Reviewed by: Date Reviewed by: Date PRINCIPLE

More information